Xu et al. demonstrated that metformin activates the SIRT1/FOXO1 pathway, promoting the expression of LC3-II and Beclin1, which reduces glomerular basement membrane thickness and foot process fusion in DKD rats. This evidence concerns the gene FOXO1 and diabetic kidney disease.